Minocycline	B:C0026187
reduces	O
mechanical	O
allodynia	I:C2936719
and	O
depressive	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
in	O
type	O
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
mellitus	I:C0011854
in	O
the	O
rat	O
.	O

Minocycline	O
reduces	O
mechanical	B:C2936719
allodynia	I:C2936719
and	O
depressive	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
in	O
type	O
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
mellitus	I:C0011854
in	O
the	O
rat	O
.	O

Minocycline	O
reduces	O
mechanical	O
allodynia	I:C2936719
and	O
depressive	B:C0011570
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
in	O
type	O
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
mellitus	I:C0011854
in	O
the	O
rat	O
.	O

Minocycline	O
reduces	O
mechanical	O
allodynia	I:C2936719
and	O
depressive	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
in	O
type	B:C0011854
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
mellitus	I:C0011854
in	O
the	O
rat	O
.	O

Minocycline	O
reduces	O
mechanical	O
allodynia	I:C2936719
and	O
depressive	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
in	O
type	O
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
mellitus	I:C0011854
in	O
the	O
rat	B:C0034693
.	O

A	O
common	O
and	O
devastating	O
complication	B:C0544688
of	O
diabetes	O
mellitus	I:C0011854
is	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
(	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
)	O
that	O
can	O
be	O
accompanied	O
by	O
emotional	O
disorders	I:C0233459
such	O
as	O
depression	O
.	O

A	O
common	O
and	O
devastating	O
complication	O
of	O
diabetes	B:C0011854
mellitus	I:C0011854
is	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
(	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
)	O
that	O
can	O
be	O
accompanied	O
by	O
emotional	O
disorders	I:C0233459
such	O
as	O
depression	O
.	O

A	O
common	O
and	O
devastating	O
complication	O
of	O
diabetes	O
mellitus	I:C0011854
is	O
painful	B:C0751074
diabetic	I:C0751074
neuropathy	I:C0751074
(	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
)	O
that	O
can	O
be	O
accompanied	O
by	O
emotional	O
disorders	I:C0233459
such	O
as	O
depression	O
.	O

A	O
common	O
and	O
devastating	O
complication	O
of	O
diabetes	O
mellitus	I:C0011854
is	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
(	O
painful	B:C0751074
diabetic	I:C0751074
neuropathy	I:C0751074
)	O
that	O
can	O
be	O
accompanied	O
by	O
emotional	O
disorders	I:C0233459
such	O
as	O
depression	O
.	O

A	O
common	O
and	O
devastating	O
complication	O
of	O
diabetes	O
mellitus	I:C0011854
is	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
(	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
)	O
that	O
can	O
be	O
accompanied	O
by	O
emotional	B:C0233459
disorders	I:C0233459
such	O
as	O
depression	O
.	O

A	O
common	O
and	O
devastating	O
complication	O
of	O
diabetes	O
mellitus	I:C0011854
is	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
(	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
)	O
that	O
can	O
be	O
accompanied	O
by	O
emotional	O
disorders	I:C0233459
such	O
as	O
depression	B:C0011570
.	O

A	O
few	O
studies	O
have	O
suggested	O
that	O
minocycline	B:C0026187
that	O
inhibits	O
microglia	O
may	O
attenuate	O
pain	O
hypersensitivity	O
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
.	O

A	O
few	O
studies	O
have	O
suggested	O
that	O
minocycline	O
that	O
inhibits	O
microglia	B:C0206116
may	O
attenuate	O
pain	O
hypersensitivity	O
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
.	O

A	O
few	O
studies	O
have	O
suggested	O
that	O
minocycline	O
that	O
inhibits	O
microglia	O
may	O
attenuate	O
pain	O
hypersensitivity	O
in	O
painful	B:C0751074
diabetic	I:C0751074
neuropathy	I:C0751074
.	O

Moreover	O
,	O
a	O
recent	O
study	O
reported	O
that	O
minocycline	B:C0026187
has	O
an	O
acute	O
antidepressive	I:C1457887
-	I:C1457887
like	I:C1457887
effect	I:C1457887
in	O
diabetic	O
animals	I:C0003062
.	O

Moreover	O
,	O
a	O
recent	O
study	O
reported	O
that	O
minocycline	O
has	O
an	O
acute	B:C1457887
antidepressive	I:C1457887
-	I:C1457887
like	I:C1457887
effect	I:C1457887
in	O
diabetic	O
animals	I:C0003062
.	O

Moreover	O
,	O
a	O
recent	O
study	O
reported	O
that	O
minocycline	O
has	O
an	O
acute	O
antidepressive	I:C1457887
-	I:C1457887
like	I:C1457887
effect	I:C1457887
in	O
diabetic	B:C0003062
animals	I:C0003062
.	O

Here	O
we	O
studied	O
whether	O
(	O
i	O
)	O
prolonged	O
minocycline	B:C0026187
treatment	O
suppresses	O
pain	O
behaviour	O
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
,	O
(	O
ii	O
)	O
the	O
minocycline	O
effect	O
varies	O
with	O
submodality	O
of	I:C0030193
pain	I:C0030193
,	O
and	O
(	O
iii	O
)	O
the	O
suppression	O
of	O
pain	O
behaviour	O
by	O
prolonged	O
minocycline	O
treatment	O
is	O
associated	O
with	O
antidepressive	O
-	I:C1457887
like	I:C1457887
effect	I:C1457887
.	O

Here	O
we	O
studied	O
whether	O
(	O
i	O
)	O
prolonged	O
minocycline	O
treatment	O
suppresses	O
pain	O
behaviour	O
in	O
painful	B:C0751074
diabetic	I:C0751074
neuropathy	I:C0751074
,	O
(	O
ii	O
)	O
the	O
minocycline	O
effect	O
varies	O
with	O
submodality	O
of	I:C0030193
pain	I:C0030193
,	O
and	O
(	O
iii	O
)	O
the	O
suppression	O
of	O
pain	O
behaviour	O
by	O
prolonged	O
minocycline	O
treatment	O
is	O
associated	O
with	O
antidepressive	O
-	I:C1457887
like	I:C1457887
effect	I:C1457887
.	O

Here	O
we	O
studied	O
whether	O
(	O
i	O
)	O
prolonged	O
minocycline	O
treatment	O
suppresses	O
pain	O
behaviour	O
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
,	O
(	O
ii	O
)	O
the	O
minocycline	B:C0026187
effect	O
varies	O
with	O
submodality	O
of	I:C0030193
pain	I:C0030193
,	O
and	O
(	O
iii	O
)	O
the	O
suppression	O
of	O
pain	O
behaviour	O
by	O
prolonged	O
minocycline	O
treatment	O
is	O
associated	O
with	O
antidepressive	O
-	I:C1457887
like	I:C1457887
effect	I:C1457887
.	O

Here	O
we	O
studied	O
whether	O
(	O
i	O
)	O
prolonged	O
minocycline	O
treatment	O
suppresses	O
pain	O
behaviour	O
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
,	O
(	O
ii	O
)	O
the	O
minocycline	O
effect	O
varies	O
with	O
submodality	B:C0030193
of	I:C0030193
pain	I:C0030193
,	O
and	O
(	O
iii	O
)	O
the	O
suppression	O
of	O
pain	O
behaviour	O
by	O
prolonged	O
minocycline	O
treatment	O
is	O
associated	O
with	O
antidepressive	O
-	I:C1457887
like	I:C1457887
effect	I:C1457887
.	O

Here	O
we	O
studied	O
whether	O
(	O
i	O
)	O
prolonged	O
minocycline	O
treatment	O
suppresses	O
pain	O
behaviour	O
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
,	O
(	O
ii	O
)	O
the	O
minocycline	O
effect	O
varies	O
with	O
submodality	O
of	I:C0030193
pain	I:C0030193
,	O
and	O
(	O
iii	O
)	O
the	O
suppression	O
of	O
pain	O
behaviour	O
by	O
prolonged	O
minocycline	B:C0026187
treatment	O
is	O
associated	O
with	O
antidepressive	O
-	I:C1457887
like	I:C1457887
effect	I:C1457887
.	O

Here	O
we	O
studied	O
whether	O
(	O
i	O
)	O
prolonged	O
minocycline	O
treatment	O
suppresses	O
pain	O
behaviour	O
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
,	O
(	O
ii	O
)	O
the	O
minocycline	O
effect	O
varies	O
with	O
submodality	O
of	I:C0030193
pain	I:C0030193
,	O
and	O
(	O
iii	O
)	O
the	O
suppression	O
of	O
pain	O
behaviour	O
by	O
prolonged	O
minocycline	O
treatment	B:C0087111
is	O
associated	O
with	O
antidepressive	O
-	I:C1457887
like	I:C1457887
effect	I:C1457887
.	O

Here	O
we	O
studied	O
whether	O
(	O
i	O
)	O
prolonged	O
minocycline	O
treatment	O
suppresses	O
pain	O
behaviour	O
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
,	O
(	O
ii	O
)	O
the	O
minocycline	O
effect	O
varies	O
with	O
submodality	O
of	I:C0030193
pain	I:C0030193
,	O
and	O
(	O
iii	O
)	O
the	O
suppression	O
of	O
pain	O
behaviour	O
by	O
prolonged	O
minocycline	O
treatment	O
is	O
associated	O
with	O
antidepressive	B:C1457887
-	I:C1457887
like	I:C1457887
effect	I:C1457887
.	O

The	O
experiments	B:C0205664
were	O
performed	O
in	O
streptozotocin	O
-	O
induced	O
rat	O
model	O
of	O
type	O
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
.	O

The	O
experiments	O
were	O
performed	O
in	O
streptozotocin	B:C0038432
-	O
induced	O
rat	O
model	O
of	O
type	O
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
.	O

The	O
experiments	O
were	O
performed	O
in	O
streptozotocin	O
-	O
induced	O
rat	B:C0034693
model	O
of	O
type	O
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
.	O

The	O
experiments	O
were	O
performed	O
in	O
streptozotocin	O
-	O
induced	O
rat	O
model	B:C0599779
of	O
type	O
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
.	O

The	O
experiments	O
were	O
performed	O
in	O
streptozotocin	O
-	O
induced	O
rat	O
model	O
of	O
type	B:C0011854
-	I:C0011854
1	I:C0011854
diabetes	I:C0011854
.	O

Pain	O
behaviour	O
was	O
evoked	O
by	O
innocuous	O
(	O
monofilaments	O
)	O
and	O
noxious	O
(	O
paw	O
pressure	O
)	O
mechanical	B:C1285354
stimulation	I:C1285354
,	O
innocuous	O
cold	I:C0009443
(	O
acetone	O
drops	I:C0991568
)	O
and	O
noxious	O
heat	O
(	O
radiant	O
heat	O
)	O
.	O

Pain	O
behaviour	O
was	O
evoked	O
by	O
innocuous	O
(	O
monofilaments	O
)	O
and	O
noxious	O
(	O
paw	O
pressure	O
)	O
mechanical	O
stimulation	I:C1285354
,	O
innocuous	B:C0009443
cold	I:C0009443
(	O
acetone	O
drops	I:C0991568
)	O
and	O
noxious	O
heat	O
(	O
radiant	O
heat	O
)	O
.	O

Pain	O
behaviour	O
was	O
evoked	O
by	O
innocuous	O
(	O
monofilaments	O
)	O
and	O
noxious	O
(	O
paw	O
pressure	O
)	O
mechanical	O
stimulation	I:C1285354
,	O
innocuous	O
cold	I:C0009443
(	O
acetone	B:C0991568
drops	I:C0991568
)	O
and	O
noxious	O
heat	O
(	O
radiant	O
heat	O
)	O
.	O

Depression	B:C0011570
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
was	O
assessed	O
using	O
forced	O
swimming	I:C0683444
test	I:C0683444
.	O

Depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
was	O
assessed	O
using	O
forced	B:C0683444
swimming	I:C0683444
test	I:C0683444
.	O

Minocycline	B:C0026187
treatment	O
(	O
daily	O
80	O
mg	O
/	O
kg	O
per	O
os	O
)	O
of	O
three	O
-	O
week	O
duration	O
started	O
four	O
weeks	O
after	O
induction	O
of	O
diabetes	O
.	O

Minocycline	O
treatment	O
(	O
daily	O
80	O
mg	O
/	O
kg	O
per	O
os	O
)	O
of	O
three	O
-	O
week	O
duration	O
started	O
four	O
weeks	O
after	O
induction	O
of	O
diabetes	B:C0011847
.	O

Diabetes	B:C0011847
induced	O
mechanical	O
allodynia	I:C2936719
and	O
hyperalgesia	O
,	O
cold	O
allodynia	I:C0458247
,	O
heat	O
hypoalgesia	I:C0085625
,	O
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
.	O

Diabetes	O
induced	O
mechanical	B:C2936719
allodynia	I:C2936719
and	O
hyperalgesia	O
,	O
cold	O
allodynia	I:C0458247
,	O
heat	O
hypoalgesia	I:C0085625
,	O
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
.	O

Diabetes	O
induced	O
mechanical	O
allodynia	I:C2936719
and	O
hyperalgesia	B:C0020429
,	O
cold	O
allodynia	I:C0458247
,	O
heat	O
hypoalgesia	I:C0085625
,	O
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
.	O

Diabetes	O
induced	O
mechanical	O
allodynia	I:C2936719
and	O
hyperalgesia	O
,	O
cold	B:C0458247
allodynia	I:C0458247
,	O
heat	O
hypoalgesia	I:C0085625
,	O
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
.	O

Diabetes	O
induced	O
mechanical	O
allodynia	I:C2936719
and	O
hyperalgesia	O
,	O
cold	O
allodynia	I:C0458247
,	O
heat	B:C0085625
hypoalgesia	I:C0085625
,	O
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
.	O

Diabetes	O
induced	O
mechanical	O
allodynia	I:C2936719
and	O
hyperalgesia	O
,	O
cold	O
allodynia	I:C0458247
,	O
heat	O
hypoalgesia	I:C0085625
,	O
and	O
depression	B:C0011570
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
.	O

Minocycline	B:C0026187
treatment	O
significantly	O
attenuated	O
mechanical	O
allodynia	I:C2936719
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
,	O
while	O
it	O
failed	O
to	O
produce	O
significant	O
changes	O
in	O
mechanical	O
hyperalgesia	I:C2936719
,	O
cold	O
allodynia	I:C0458247
or	O
heat	O
hypoalgesia	I:C0085625
.	O

Minocycline	O
treatment	B:C0087111
significantly	O
attenuated	O
mechanical	O
allodynia	I:C2936719
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
,	O
while	O
it	O
failed	O
to	O
produce	O
significant	O
changes	O
in	O
mechanical	O
hyperalgesia	I:C2936719
,	O
cold	O
allodynia	I:C0458247
or	O
heat	O
hypoalgesia	I:C0085625
.	O

Minocycline	O
treatment	O
significantly	O
attenuated	O
mechanical	B:C2936719
allodynia	I:C2936719
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
,	O
while	O
it	O
failed	O
to	O
produce	O
significant	O
changes	O
in	O
mechanical	O
hyperalgesia	I:C2936719
,	O
cold	O
allodynia	I:C0458247
or	O
heat	O
hypoalgesia	I:C0085625
.	O

Minocycline	O
treatment	O
significantly	O
attenuated	O
mechanical	O
allodynia	I:C2936719
and	O
depression	B:C0011570
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
,	O
while	O
it	O
failed	O
to	O
produce	O
significant	O
changes	O
in	O
mechanical	O
hyperalgesia	I:C2936719
,	O
cold	O
allodynia	I:C0458247
or	O
heat	O
hypoalgesia	I:C0085625
.	O

Minocycline	O
treatment	O
significantly	O
attenuated	O
mechanical	O
allodynia	I:C2936719
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
,	O
while	O
it	O
failed	O
to	O
produce	O
significant	O
changes	O
in	O
mechanical	B:C2936719
hyperalgesia	I:C2936719
,	O
cold	O
allodynia	I:C0458247
or	O
heat	O
hypoalgesia	I:C0085625
.	O

Minocycline	O
treatment	O
significantly	O
attenuated	O
mechanical	O
allodynia	I:C2936719
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
,	O
while	O
it	O
failed	O
to	O
produce	O
significant	O
changes	O
in	O
mechanical	O
hyperalgesia	I:C2936719
,	O
cold	B:C0458247
allodynia	I:C0458247
or	O
heat	O
hypoalgesia	I:C0085625
.	O

Minocycline	O
treatment	O
significantly	O
attenuated	O
mechanical	O
allodynia	I:C2936719
and	O
depression	O
-	I:C0011570
like	I:C0011570
behaviour	I:C0011570
,	O
while	O
it	O
failed	O
to	O
produce	O
significant	O
changes	O
in	O
mechanical	O
hyperalgesia	I:C2936719
,	O
cold	O
allodynia	I:C0458247
or	O
heat	B:C0085625
hypoalgesia	I:C0085625
.	O

The	O
results	O
indicate	O
that	O
prolonged	O
per	O
oral	O
treatment	O
with	O
minocycline	B:C0026187
has	O
a	O
sustained	O
mechanical	O
antiallodynic	I:C1457887
and	O
antidepressive	O
-	I:C1457887
like	I:C1457887
effect	I:C1457887
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
.	O

The	O
results	O
indicate	O
that	O
prolonged	O
per	O
oral	O
treatment	O
with	O
minocycline	O
has	O
a	O
sustained	O
mechanical	B:C1457887
antiallodynic	I:C1457887
and	O
antidepressive	O
-	I:C1457887
like	I:C1457887
effect	I:C1457887
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
.	O

The	O
results	O
indicate	O
that	O
prolonged	O
per	O
oral	O
treatment	O
with	O
minocycline	O
has	O
a	O
sustained	O
mechanical	O
antiallodynic	I:C1457887
and	O
antidepressive	B:C1457887
-	I:C1457887
like	I:C1457887
effect	I:C1457887
in	O
painful	O
diabetic	I:C0751074
neuropathy	I:C0751074
.	O

The	O
results	O
indicate	O
that	O
prolonged	O
per	O
oral	O
treatment	O
with	O
minocycline	O
has	O
a	O
sustained	O
mechanical	O
antiallodynic	I:C1457887
and	O
antidepressive	O
-	I:C1457887
like	I:C1457887
effect	I:C1457887
in	O
painful	B:C0751074
diabetic	I:C0751074
neuropathy	I:C0751074
.	O

These	O
results	O
support	O
the	O
proposal	O
that	O
minocycline	B:C0026187
might	O
provide	O
a	O
treatment	O
option	I:C0683525
for	O
attenuating	O
sensory	O
and	O
comorbid	O
emotional	O
symptoms	O
in	O
chronic	O
PDN	I:C0393830
.	O

These	O
results	O
support	O
the	O
proposal	O
that	O
minocycline	O
might	O
provide	O
a	O
treatment	B:C0683525
option	I:C0683525
for	O
attenuating	O
sensory	O
and	O
comorbid	O
emotional	O
symptoms	O
in	O
chronic	O
PDN	I:C0393830
.	O

These	O
results	O
support	O
the	O
proposal	O
that	O
minocycline	O
might	O
provide	O
a	O
treatment	O
option	I:C0683525
for	O
attenuating	O
sensory	O
and	O
comorbid	O
emotional	O
symptoms	O
in	O
chronic	B:C0393830
PDN	I:C0393830
.	O

